Over 80% of these fatalities result from heart attacks and strokes. December is notorious for being the biggest month for heart attacks, with one of the most dangerous being the widowmaker heart ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of ...

In patients with metabolic dysfunction-associated steatotic liver disease, there is increased risk for heart failure with preserved ejection fraction.

Lp(a)] plays a key role in assessing cardiovascular risk, making awareness efforts equally essential for prevention and early intervention.

The FDA has accepted for Priority Review the sNDA for finerenone for heart failure with mildly reduced or preserved ejection fraction.

Our findings suggest deeper issues are contributing to the increase in the disease, particularly in Black women. Barriers to health care are critical. These include insurance gaps, transportation ...